drugset / Trial / NCT00877929

Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

NCT00877929 ↗

Phase 3 Completed 706 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To demonstrate that the fixed dose combination of telmisartan and amlodipine is more effective in lowering blood pressure.

Timeline

Start
2009-02
Primary completion
2010-05
Completion
—

Outcome

Met primary endpoint

registry p = 0.0001; Mean Difference (Final Values) -6.1 (95% CI -7.9 to -4.2) NCT00877929 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 10 mg —
Subject Telmisartan Other / unclassified 80 mg —

Indications